ASRS
BCRX icon

Arizona State Retirement System’s BioCryst Pharmaceuticals BCRX Stock Holding History

Arizona State Retirement System’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$571K Buy
57,093
+166
+0.3% +$1.5K ﹤0.01% 1472
2026
Q1 		$542K Buy
56,927
+845
+2% +$6.56K ﹤0.01% 1417
2025
Q4 		$437K Sell
56,082
-2,706
-5% -$19.6K ﹤0.01% 1554
2025
Q3 		$446K Buy
58,788
+854
+1% +$7.11K ﹤0.01% 1575
2025
Q2 		$519K Buy
57,934
+1,556
+3% +$14.5K ﹤0.01% 1433
2025
Q1 		$423K Sell
56,378
-623
-1% -$5.03K ﹤0.01% 1504
2024
Q4 		$429K Buy
57,001
+3,518
+7% +$26.7K ﹤0.01% 1572
2024
Q3 		$406K Buy
53,483
+1,542
+3% +$11.7K ﹤0.01% 1594
2024
Q2 		$321K Buy
51,941
+1,283
+3% +$7.08K ﹤0.01% 1667
2024
Q1 		$257K Sell
50,658
-2,314
-4% -$13K ﹤0.01% 1794
2023
Q4 		$317K Sell
52,972
-823
-2% -$4.77K ﹤0.01% 1694
2023
Q3 		$381K Buy
53,795
+863
+2% +$6.2K ﹤0.01% 1535
2023
Q2 		$373K Sell
52,932
-1,085
-2% -$8.71K ﹤0.01% 1586
2023
Q1 		$451K Buy
54,017
+1,548
+3% +$14.9K ﹤0.01% 1467
2022
Q4 		$602K Buy
52,469
+2,026
+4% +$25.3K 0.01% 1268
2022
Q3 		$636K Buy
50,443
+400
+0.8% +$5.15K 0.01% 1184
2022
Q2 		$529K Buy
50,043
+1,403
+3% +$14.5K 0.01% 1318
2022
Q1 		$791K Buy
48,640
+498
+1% +$7.99K 0.01% 1193
2021
Q4 		$667K Sell
48,142
-261
-0.5% -$3.45K 0.01% 1363
2021
Q3 		$696K Buy
48,403
+321
+0.7% +$5.06K 0.01% 1329
2021
Q2 		$760K Sell
48,082
-3,317
-6% -$45.1K 0.01% 1296
2021
Q1 		$523K Buy
51,399
+195
+0.4% +$2.01K ﹤0.01% 1512
2020
Q4 		$381K Sell
51,204
-1,016
-2% -$5.24K ﹤0.01% 1607
2020
Q3 		$179K Buy
52,220
+17,448
+50% +$74.8K ﹤0.01% 1808
2020
Q2 		$166K Sell
34,772
-1,396
-4% -$5.58K ﹤0.01% 1698
2020
Q1 		$72K Buy
+36,168
New +$99.6K ﹤0.01% 1712

Other funds holding BCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Arizona State Retirement System's BCRX Position: Q2 2026 in Review

Arizona State Retirement System increased its BioCryst Pharmaceuticals (BCRX) stake by 0.29% in Q2 2026, buying an estimated $1.5K and bringing the position to 57,093 shares worth $571K. The position accounts for ﹤0.01% of the portfolio, ranked #1472.

Arizona State Retirement System first reported a position in BCRX in Q1 2020 and has held it in 26 quarters since. The position peaked at $791K in Q1 2022. 318 funds tracked by Wall St. Rank hold BCRX as of Q2 2026.

  • Arizona State Retirement System held 57,093 shares of BioCryst Pharmaceuticals worth $571K as of Q2 2026.
  • Arizona State Retirement System bought 166 BioCryst Pharmaceuticals shares in Q2 2026, an estimated $1.5K.
  • BioCryst Pharmaceuticals made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1472 holding.
  • Arizona State Retirement System first reported a position in BioCryst Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Arizona State Retirement System's BioCryst Pharmaceuticals position peaked at $791K in Q1 2022.
  • 318 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.